Clinical Trial Update: Study of Apixaban in Patients Receiving Hemodiafiltration [Phase 2]

View source ↗

Summary

Phase 2 trial update of apixaban in patients receiving hemodiafiltration has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Hospital Universitari de Bellvitge | Conditions: Atrial Fibrillation, Hemodialysis Complication | Phase 2 | Status: COMPLETED